Hypothermia prolongs activation of NF-κB and augments generation of inflammatory cytokines

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Fairchild, Karen D ^a,d   Singh, Ishwar S ^a   Patel, Sandip ^a   Drysdale, Beth E ^c   Viscardi, Rose M ^a   Hester, Lisa ^a,b   Lazusky, Heather M ^a   Hasday, Jeffrey D ^a,b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

I B; Interleukin 1; Lipopolysaccharide; Monocyte; Tumor necrosis factor

Indexed keywords

CYTOKINE; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GEL MOBILITY SHIFT ASSAY; HEART INJURY; HUMAN; HUMAN CELL; HYPOTHERMIA; IMMUNOBLOTTING; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; MONOCYTE; MONONUCLEAR PHAGOCYTE; NEUROPROTECTION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TEMPERATURE DEPENDENCE;

CELL LINE; GENE EXPRESSION; HUMANS; HYPOTHERMIA, INDUCED; I-KAPPA B PROTEINS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; RNA, MESSENGER; SEPSIS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

TRIXIS;

EID: 3242671607     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00507.2003     Document Type: Article

References (69)

1. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, and Hay RT. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol Cell Biol 15: 2689-2696, 1995.
2. Armstrong C. Some recent research in the field of neurotropic viruses with especial reference to lymphocytic choriomeningitis and herpes simplex. Mil Surg 91: 129-145, 1942.
3. Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson W, Wright P, Dupont WD, and Swindell BB. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 27: 699-707, 1999.
4. Baeuerle P and Baltimore D. NF-κB: ten years after. Cell 87: 13-20, 1996.
5. Bazzoni F, Kruys V, Shakhov A, Jongeneel CV, and Beutler B. Analysis of tumor necrosis factor promoter responses to ultraviolet light. J Clin Invest 93: 56-62, 1994.
6. Beilin B, Shavit Y, Razumovsky J, Wolloch Y, Zeidel A, and Bessler H. Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 89: 1133-1140, 1998.
7. Belasco JG and Brawerman G. Experimental approaches to the study of mRNA decay. In: Control of Messenger RNA Stability, edited by Belasco JG and Brawerman G. San Diego, CA: Academic, 1993, p. 475-493.
8. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, and Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346: 557-563, 2002.
9. Bernheim HA and Kluger MJ. Fever: effect of drug-induced antipyresis on survival. Science 193: 237-239, 1976.
10. Beutler B, Krochin N, Milsark IW, Luedke C, and Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977-979, 1986.
11. Beutler B, Milsark I, and Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science 229: 869-871, 1985.
12. Bierens JJ, Uitslager R, Swenne-van Ingen MM, van Stiphout WA, and Knape JT. Accidental hypothermia: incidence, risk factors and clinical course of patients admitted to hospital. Eur J Emerg Med 2: 38-46, 1995.
13. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, and Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197: 1119-1124, 2003.
14. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, and Maniatis T. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9: 1586-1597, 1995.
15. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
16. Clemmer TP, Fisher CJ Jr, Bone RC, Slotman GJ, Metz CA, and Thomas FO. Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 20: 1395-1401, 1992.
17. Covert JB and Reynolds WW. Survival value of fever in fish. Nature 267: 43-45, 1977.
18. Cross A, Asher L, Seguin M, Yuan L, Kelly N, Hammack C, Sadoff J, and Gemski P Jr. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J Clin Invest 96: 676-686, 1995.
19. Cross AS, Sadoff JC, Kelly N, Bernton E, and Gemski P. Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1α protects mice from lethal bacterial infection. J Exp Med 169: 2021-2027, 1989.
20. Dinarello CA. Cytokines as endogenous pyrogens. In: Fever: Basic Mechanisms and Management (2nd ed.), edited by Mackowiak PA. New York: Raven, 1996, p. 87-116.
21. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, and Norton JA. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 149: 1666-1670, 1992.
22. Drouet C, Shakhov AN, and Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J Immunol 147: 1694-1700, 1991.
23. Dubin WL, Martin TR, Swoveland P, Leturcq DJ, Moriarty AM, Tobias PS, Bleecker ER, Goldblum SE, and Hasday JD. Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol Lung Mol Cell Physiol 270: L736-L744, 1996.
24. Economou, JS, Rhoades K, Essner R, McBride WH, Gasson JC, and Morton DL. Genetic analysis of the human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J Exp Med 170: 321-326, 1989.
25. Elstad MR, Parker CJ, Cowley FS, Wilcox LA, McIntyre TM, Prescott SM, and Zimmerman GA. CD11b/CD18 integrin and a β-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J Immunol 152: 220-230, 1994.
26. Ensor JE, Crawford EK, and Hasday JD. Warming macrophages to febrile range destabilizes tumor necrosis factor-α mRNA without inducing heat shock. Am J Physiol Cell Physiol 269: C1140-C1146, 1995.
27. Ensor JE, Wiener SM, McCrea KA, Viscardi RM, Crawford EK, and Hasday JD. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-α expression. Am J Physiol Cell Physiol 266: C967-C974, 1994.
28. Fairchild KD, Viscardi RM, Hester L, Singh IS, and Hasday JD. Effects of hypothermia and hyperthermia on cytokine production by cultured human mononuclear phagocytes from adults and newborns. J Interferon Cytokine Res 20: 1049-1055, 2000.
29. Godambe SA, Chaplin DD, and Bellone CJ. Regulation of IL-1 gene expression: differential responsiveness of murine macrophage lines. Cytokine 5: 327-335, 1993.
30. Greenberg ME and Belasco JG. Control of the decay of labile protooncogene and cytokine mRNAs. In: Control of Messenger RNA Stability, edited by Belasco JG and Brawerman G. San Diego, CA: Academic, 1993, p. 199-218.
31. Han J, Brown T, and Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171: 465-475, 1990.
32. Hasday JD, Fairchild KD, and Shanholtz C. The role of fever in the infected host. Microbes Infect 2: 1891-1904, 2000.
33. Hasday JD and Singh IS. Fever and the heat shock response: distinct, partially overlapping processes. Cell Stress Chaperones 5: 471-480, 2000.
34. Hentze MW. Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. Biochim Biophys Acta 1090: 281-292, 1991.
35. Irazuzta JE, Pretzlaff RK, Zingarelli B, Xue V, and Zemlan F. Modulation of nuclear factor-κβ activation and decreased markers of neurological injury associated with hypothermic therapy in experimental bacterial meningitis. Crit Care Med 30: 2553-2559, 2002.
36. Jiang Q, Cross AS, Singh IS, Chem TT, Viscardi RM, and Hasday JD. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun 68: 1265-1270, 2000.
37. Jiang Q, Detolla L, Singh IS, Gatdula L, Fitzgerald B, van Rooijen N, Cross AS, and Hasday JD. Exposure to febrile temperature upregulates expression of pyrogenic cytokines in endotoxin-challenged mice. Am J Physiol Regul Integr Comp Physiol 276: R1653-R1660, 1999.
38. Jongeneel CV, Shakhov AN, Nedospasov SA, and Cerottini JC. Molecular control of tissue-specific expression at the mouse TNF locus. Eur J Immunol 19: 549-552, 1989.
39. Jurkovich GJ, Greiser WB, Luterman A, and Curreri PW. Hypothermia in trauma victims: an ominous predictor of survival. J Trauma 27: 1019-1024, 1987.
40. Kamme F, Campbell K, and Wieloch T. Biphasic expression of the fos and jun families of transcription factors following transient forebrain ischaemia in the rat. Effect of hypothermia. Eur J Neurosci 7: 2007-2016, 1995.
41. Kimura A, Sakurada S, Ohkuni H, Todome Y, and Kurata K. Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells. Crit Care Med 30: 1499-1502, 2002.
42. Kum WW, Cameron SB, Hung RW, Kalyan S, and Chow AW. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells. Infect Immun 69: 7544-7549, 2001.
43. Kurz A, Sessler DI, and Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infections and shorten hospitalization. N Engl J Med 334: 1209-1215, 1996.
44. Lieberman AP, Pitha PM, and Shin ML. Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes. J Exp Med 172: 989-992, 1990.
45. Luhm J, Schromm AB, Seydel U, Brandenburg K, Wellinghausen N, Riedel E, Schumann RR, and Rink L. Hypothermia enhances the biological activity of lipopolysaccharide by altering its fluidity state. Eur J Biochem 256: 325-333, 1998.
46. Luna GK, Maier RV, Pavlin EG, Anardi D, Copass MK, and Oreskovich MR. Incidence and effect of hypothermia in seriously injured patients. J Trauma 27: 1014-1018, 1987.
47. Mathur NB, Singh A, Sharma VK, and Satyanarayana L. Evaluation of risk factors for fatal neonatal sepsis, Indian Pediatr 33: 817-822, 1996.
48. Mosser DD, Theodorakis NG, and Morimoto RI. Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. Mol Cell Biol 8: 4736-4744, 1988.
49. Ning XH, Chen SH, Xu CS, Li L, Yao LY, Qian K, Krueger JJ, Hyyti OM, and Portman MA. Hypothermic protection of the ischemic heart via alterations in apoptotic pathways as assessed by gene array analysis. J Appl Physiol 92: 2200-2207, 2002.
50. Nishiyama H, Higashitsuji H, Yokoi H, Itoh K, Danno S, Matsuda T, and Fujita J. Cloning and characterization of human CIRP (cold-inducible RNA-binding protein) cDNA and chromosomal assignment of the gene. Gene 204: 115-120, 1997.
51. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, and Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771, 2000.
52. Raabe T, Bukrinsky M, and Currie RA. Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide. J Biol Chem 273: 974-980, 1998.
53. Roberts JR, Rowe PA, and Demaine AG. Activation of NF-κB and MAP kinase cascades by hypothermic stress in endothelial cells. Cryobiology 44: 161-169, 2002.
54. Saccani S, Pantano S, and Natoli G. Two waves of nuclear factor κB recruitment to target promoters. J Exp Med 193: 1351-1359, 2001.
55. Sariban E, Imamura K, Luebbers R, and Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 81: 1506-1510, 1988.
56. Schmidt JR and Rasmussen AF Jr. The influence of environmental temperature on the course of experimental herpes simplex infection. J Infect Dis 107: 356-360, 1960.
57. Schreiber E, Matthias P, Muller MM, and Schaffner W. Rapid detection of octamer binding protein with mini extracts prepared from a small number of cells. Nucleic Acids Res 17: 6419-0000, 1989.
58. 3. J Leukoc Biol 59: 555-561, 1996.
59. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, and Jongeneel CV. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 171: 35-47, 1990.
60. Singh IS, Calderwood S, Kalvakolanu I, Viscardi R, and Hasday JD. Inhibition of tumor necrosis factor-α transcription in macrophages exposed to febrile range temperature: a possible role for heat shock factor-1. J Biol Chem 275: 9841-9848, 2000.
61. Sutcliffe IT, Smith HA, Stanimirovic D, and Hutchison JS. Effects of moderate hypothermia on 1L-1 β-induced leukocyte rolling and adhesion in pia1 microcirculation of mice and on proinflammatory gene expression in human cerebral endothelial cells. J Cereb Blood Flow Metab 21: 1310-1319, 2001.
62. Taffet SM, Singhel KJ, Overholtzer JF, and Shurtleff SA. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell Immunol 120: 291-300, 1989.
63. Tam W, Lee L, Davis L, and Sen R. Cytoplasmic sequestration of rel proteins by IκBα requires CRM1-dependent nuclear export. Mol Cell Biol 20: 2269-2284, 2000.
64. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J Biol Chem 274: 8531-8538, 1999.
65. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, and Lowry SF. Cachectin/ tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167: 1211-1227, 1988.
66. Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, and Goldfeld AE. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor α promoter in vivo. Mol Cell Biol 20: 6084-6094, 2000.
67. Waage A and Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 167: 1987-1992, 1988.
68. Webb P. Temperatures of skin, subcutaneous tissue, muscle and core in resting men in cold, comfortable and hot conditions. Eur J Appl Physiol 64: 471-476, 1992.
69. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, and Arditi M. Bacterial lipopolysaccharide activates nuclear factor-κβ through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274: 7611-7614, 1999.